Publication | Open Access

Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation

MedicinePotential ApplicationPharmacological AgentNeuropharmacologyNeuropeptide ReceptorPharmacotherapyNeuroscienceNeurologyNon-peptide LigandPharmacologyDrug DiscoveryNeuropeptides